Cogent Biosciences
Cogent Biosciences is a biotechnology company developing precision therapies for unmet medical needs, with a focus on rare diseases and oncology. The company is engaged in launching new treatments and expanding its scientific research.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2014
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, including cancers, autoimmune conditions, and rare diseases. The company leverages validated biology to design best-in-class small molecule therapeutics, with its lead program bezuclastinib targeting conditions such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST). Cogent operates discovery and development offices in Boulder, Colorado and Waltham, Massachusetts, and is actively advancing clinical-stage programs including a Phase 3 trial and an FDA-accepted NDA for bezuclastinib.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cogent Biosciences.
90% above the average for this role
Sep 3, 2019
Clinical Research Associate I/ Clinical Research Associate II
Precision for Medicine
Clinical Research Associate II
Precision for Medicine
Senior Clinical Research Associate
Precision for Medicine
Clinical Trial Manager (based in Australia / Singapore)
Precision for Medicine
National Payer Manager
Telix Pharmaceuticals
Director, Clinical Supply Chain (Clinical Supply), Late Stage
Jade Biosciences